ACGX yields 5464.48% · PFE yields 6.13%● Live data
📍 ACGX pulled ahead of the other in Year 1
Combined, ACGX + PFE cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of ACGX + PFE for your $10,000?
Alliance Creative Group, Inc. operates as a creative packaging and digital engagement company in the United States. The company provides creative and design services, including advertising campaigns, art direction, brand identity, graphic design, strategy and planning, logo design, Website design, collateral design, video production, conversion copywriting, blog and keyword planning, package design, and photography; and club packs, corrugate, flexible, folding carton, pallet display, pre-print, custom, stock, and thermo-forming packaging services. It also offers supply chain management services, such as third-party logistics, trucking and distribution, vendor managed inventory, and warehousing; commercial, digital, direct mail, grand format, large format, offset, catalog, design support, outdoor signage, and Web printing services; and brand audit and research, brand strategy, communication planning, content planning, event planning, event advisory, and PR advisory services. In addition, the company provides content creation, online marketing, customer engagement, business consulting and strategic marketing, software development, digital engagement, and logistics/VMI services. It offers its services under the St. Louis Packaging, STL Graphics, Snap Graphics, Print4aCause, CoporateGifts4aCause, and PeopleVine brand names to automotive, beauty and wellness, confectionery, food and beverage, gaming and electronics, home enhancement, music and entertainment, pet care, restaurant, sports, technology, and wine and spirits industries. The company was formerly known as Invicta Group, Inc. and changed its name to Alliance Creative Group, Inc. in November 2010. Alliance Creative Group, Inc. was founded in 2000 and is headquartered in East Dundee, Illinois.
Full ACGX Calculator →Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Full PFE Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.